SLIT3 and hepatocellular carcinoma: Though the in vitro tumor suppressive effect of Slit3 overexpression in HCC cells was not very strong, but as we observed that the negative regulatory effect of Slit3 on tumor growth was much more obvious in the in vivo model, possibly due to its involvement in tumor angiogenesis as demonstrated by the CD31 immunohistochemical staining.